India‑Brazil trade talks highlight pharma, agriculture, and Mercosur ties

The summit also revisited the India‑Mercosur preferential trade agreement, reviewing possibilities for its expansion and modernization after bilateral trade with Mercosur members hit $20.84 billion in 2025. In the pharmaceutical arena, India pressed for a more predictable regulatory regime and better market access in Brazil, aiming to help Indian drug makers tap the large South American market. Agricultural discussions moved forward on plant‑health standards and mutual market access, laying the groundwork for timely exchanges of agri‑products.